Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization

被引:15
|
作者
Strefford, JC
Lillington, DM
Steggall, M
Lane, TM
Nouri, AME
Young, BD
Oliver, RTD
机构
[1] Univ London Queen Mary & Westfield Coll, Med Oncol Unit, Imperial Canc Res Fund, London E1 4NS, England
[2] St Bartholomews Hosp, Canc Serv Directorate, Dept Med Oncol, London, England
关键词
D O I
10.1016/S0165-4608(01)00648-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bladder cancer is a common neoplasm worldwide, consisting mainly of transitional cell carcinomas, while squamous, adenocarcinoma, and sarcomatoid bladder cancers account for the remaining cases. In the present study, multiplex fluorescence in situ hybridization (M-FISH) has been used to characterize chromosome rearrangements in eight transitional and one squamous cell carcinoma cell line, RT112, of UMUC-3, 5637, CAT(wil), FGEN, EJ28, J82, 253J, and SCaBER. Alterations of chromosome 9 are the most frequent cytogenetic and molecular findings in transitional cell carcinomas of all grades and stages, while changes of chromosomes 3, 4, 8, 9, 11, 14, and 17 are also frequently observed. In the present study, alterations previously described, including del(8)(p10), del(9)(p10), del(17)(p10) and overrepresentation of chromosome 20, as well as several novel findings, were observed. These novel findings were a del(15)(q15) and isochromosome 14q, both occurring in three of nine cell lines examined. These abnormalities may reflect changes in bladder tumor biology. M-FISH represents an effective preliminary screening tool for the characterization of complex tumor karyotypes. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 50 条
  • [1] CHROMOSOME-9 LOSS DETECTED BY FLUORESCENCE IN-SITU HYBRIDIZATION IN BLADDER-CANCER
    SAUTER, G
    MOCH, H
    CARROLL, P
    KERSCHMANN, R
    MIHATSCH, MJ
    WALDMAN, FM
    INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (02) : 99 - 103
  • [2] Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization
    Yokogi, H
    Wada, Y
    MoriyamaGonda, N
    Igawa, M
    Ishibe, T
    BRITISH JOURNAL OF UROLOGY, 1996, 78 (05): : 699 - 703
  • [3] Loss of chromosome 11 and 11 p/q imbalances in bladder cancer detected by fluorescence in situ hybridization
    Voorter, CEM
    Ummelen, MIJ
    Ramaekers, FSC
    Hopman, AHN
    INTERNATIONAL JOURNAL OF CANCER, 1996, 65 (03) : 301 - 307
  • [4] Chromosomal aberrations in Bilharzial bladder cancer as detected by fluorescence in situ hybridization
    Aly, MS
    Khaled, HM
    CANCER GENETICS AND CYTOGENETICS, 1999, 114 (01) : 62 - 67
  • [5] Multiplex-fluorescence in situ hybridization for chromosome karyotyping
    Jochen B Geigl
    Sabine Uhrig
    Michael R Speicher
    Nature Protocols, 2006, 1 : 1172 - 1184
  • [6] Multiplex-fluorescence in situ hybridization for chromosome karyotyping
    Geigl, Jochen B.
    Uhrig, Sabine
    Speicher, Michael R.
    NATURE PROTOCOLS, 2006, 1 (03) : 1172 - 1184
  • [7] Numerical aberrations of chromosome 8 in gastric cancer detected by fluorescence in situ hybridization
    Panani, AD
    Ferti, AD
    Avgerinos, A
    Raptis, SA
    ANTICANCER RESEARCH, 2004, 24 (01) : 155 - 159
  • [8] Aberration of chromosomes 8 and 11 in bladder cancer as detected by fluorescence in situ hybridization
    Awata, S
    Sakagami, H
    Tozawa, K
    Sasaki, S
    Ueda, K
    Kohri, K
    UROLOGICAL RESEARCH, 2000, 28 (03): : 185 - 190
  • [9] Aberration of chromosomes 8 and 11 in bladder cancer as detected by fluorescence in situ hybridization
    Awata S.
    Sakagami H.
    Tozawa K.
    Sasaki S.
    Ueda K.
    Kohri K.
    Urological Research, 2000, 28 (3): : 185 - 190
  • [10] Chromosome 8 aberration and C-MYC copy number gain in bladder cancer detected by fluorescence in situ hybridization
    Mahdy, E
    Pan, Y
    Bergerheim, U
    Malmstöm, PU
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 107 - 107